Sign in

NCT03588260Completed

Respiratory Muscle Strength in Patients With Idiopathic Pulmonary Fibrosis

Respiratory Muscle Strength in Patients With Idiopathic Pulmonary Fibrosis: The Relationship With Exercise Capacity, Physical Activity Level, and Quality of Life

Source: ClinicalTrials.gov · Last updated 12 Jan 2024

Brief summary (registry, in English)

Respiratory muscle strength, dyspnea perception, physical activity and quality of life measurements will be performed and groups will be compared in two groups consisting of patients with idiopathic pulmonary fibrosis referred to pulmonary rehabilitation clinic and healthy volunteers in similar age range.

Status (registry)
Completed
Study type
Observational
Enrollment
60 (actual)
First submitted
4 Jul 2018
Start date
20 Jul 2018
Primary completion date
30 Dec 2023
Lead sponsor
Istanbul Medipol University Hospital
NCT number
NCT03588260

What you commit to

  • Study type: Observational
  • Participants enrolled: 60
  • From 20 Jul 2018 to the primary completion date, 30 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who use steroids for less than 1 year

Other

  • The patient does not want to participate in the study

Who the study is looking for

  • Between the ages of 18-70
  • Patients signing informed consent form
  • Patients diagnosed with idiopathic pulmonary fibrosis.

Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Yedikule Chest Disease Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.